PortfoliosLab logo
HURA vs. META
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between HURA and META is 0.11, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Performance

HURA vs. META - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in TuHURA Biosciences, Inc. (HURA) and Meta Platforms, Inc. (META). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Sharpe Ratio

HURA:

-0.52

META:

1.07

Sortino Ratio

HURA:

0.29

META:

1.54

Omega Ratio

HURA:

1.03

META:

1.20

Calmar Ratio

HURA:

-0.54

META:

1.04

Martin Ratio

HURA:

-0.97

META:

3.13

Ulcer Index

HURA:

55.07%

META:

11.32%

Daily Std Dev

HURA:

140.87%

META:

36.98%

Max Drawdown

HURA:

-100.00%

META:

-76.74%

Current Drawdown

HURA:

-100.00%

META:

-12.03%

Fundamentals

Market Cap

HURA:

$133.66M

META:

$1.62T

EPS

HURA:

-$0.96

META:

$25.71

PS Ratio

HURA:

0.00

META:

9.52

PB Ratio

HURA:

14.09

META:

8.80

Total Revenue (TTM)

HURA:

$0.00

META:

$170.36B

Gross Profit (TTM)

HURA:

-$17.64K

META:

$139.27B

EBITDA (TTM)

HURA:

-$7.65M

META:

$91.37B

Returns By Period

In the year-to-date period, HURA achieves a -25.18% return, which is significantly lower than META's 10.68% return. Over the past 10 years, HURA has underperformed META with an annualized return of -56.61%, while META has yielded a comparatively higher 23.25% annualized return.


HURA

YTD

-25.18%

1M

-21.54%

6M

-53.35%

1Y

-71.80%

3Y*

-78.66%

5Y*

-71.80%

10Y*

-56.61%

META

YTD

10.68%

1M

13.16%

6M

12.93%

1Y

39.21%

3Y*

49.77%

5Y*

23.65%

10Y*

23.25%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


TuHURA Biosciences, Inc.

Meta Platforms, Inc.

Go deeper with the Portfolio Analysis tool — backtest performance, assess risk, compare to benchmarks, and more

Risk-Adjusted Performance

HURA vs. META — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

HURA
The Risk-Adjusted Performance Rank of HURA is 3030
Overall Rank
The Sharpe Ratio Rank of HURA is 2121
Sharpe Ratio Rank
The Sortino Ratio Rank of HURA is 4444
Sortino Ratio Rank
The Omega Ratio Rank of HURA is 4343
Omega Ratio Rank
The Calmar Ratio Rank of HURA is 1717
Calmar Ratio Rank
The Martin Ratio Rank of HURA is 2727
Martin Ratio Rank

META
The Risk-Adjusted Performance Rank of META is 8080
Overall Rank
The Sharpe Ratio Rank of META is 8383
Sharpe Ratio Rank
The Sortino Ratio Rank of META is 7777
Sortino Ratio Rank
The Omega Ratio Rank of META is 7676
Omega Ratio Rank
The Calmar Ratio Rank of META is 8383
Calmar Ratio Rank
The Martin Ratio Rank of META is 7979
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

HURA vs. META - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for TuHURA Biosciences, Inc. (HURA) and Meta Platforms, Inc. (META). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current HURA Sharpe Ratio is -0.52, which is lower than the META Sharpe Ratio of 1.07. The chart below compares the historical Sharpe Ratios of HURA and META, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading data...

Go to the full Sharpe Ratio tool to analyze any stock or portfolio. Customize time frames, set your own risk-free rate, and more

Dividends

HURA vs. META - Dividend Comparison

HURA has not paid dividends to shareholders, while META's dividend yield for the trailing twelve months is around 0.31%.


TTM2024
HURA
TuHURA Biosciences, Inc.
0.00%0.00%
META
Meta Platforms, Inc.
0.31%0.34%

Drawdowns

HURA vs. META - Drawdown Comparison

The maximum HURA drawdown since its inception was -100.00%, which is greater than META's maximum drawdown of -76.74%. Use the drawdown chart below to compare losses from any high point for HURA and META.


Loading data...

Go to the full Drawdowns tool for more analysis options, including inflation-adjusted drawdowns, and more

Volatility

HURA vs. META - Volatility Comparison

TuHURA Biosciences, Inc. (HURA) has a higher volatility of 23.31% compared to Meta Platforms, Inc. (META) at 10.72%. This indicates that HURA's price experiences larger fluctuations and is considered to be riskier than META based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading data...

Financials

HURA vs. META - Financials Comparison

This section allows you to compare key financial metrics between TuHURA Biosciences, Inc. and Meta Platforms, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0010.00B20.00B30.00B40.00B50.00B202120222023202420250
42.31B
(HURA) Total Revenue
(META) Total Revenue
Values in USD except per share items